April 7, 2023 11:51 p.m. Updated: April 8, 2023 6:24 p.m.
A federal court in Texas has ruled that the 23-year-old FDA approval of mifepristone should be overturned. But a federal court in Washington has ruled the FDA must continue to make the drug available in some states.
📨 Daily news in your inbox
Sign up today for OPB’s “First Look” – your daily guide to the most important news and culture stories from around the Northwest.